StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/303% above fair value
$30.36−1.47 (-4.62%)

Close on Nov 16, 2026Market cap $2.93BP/E –Yield –

IDEAYA Biosciences r&d expenses

Research and development expenses are spending on new products and technology.

IDEAYA Biosciences's R&D Expenses for the twelve months ending Jun 30, 2026 was $374.01M, up 9.2% year over year. For fiscal 2025 it was $314.70M, up 6.8% from the year before. The highest annual figure on record is $314.70M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$314.70M+6.8%
FY2024Dec 31, 2024$294.67M+127.5%
FY2023Dec 31, 2023$129.51M+44.6%
FY2022Dec 31, 2022$89.54M+54.0%
FY2021Dec 31, 2021$58.16M+46.5%
FY2020Dec 31, 2020$39.70M+15.7%
FY2019Dec 31, 2019$34.32M+8.1%
FY2018Dec 31, 2018$31.75M+156.4%
FY2017Dec 31, 2017$12.38M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$108.69M+46.4%
Q1 FY2026Mar 31, 2026$95.73M+35.0%
Q4 FY2025Dec 31, 2025$86.60M-38.2%
Q3 FY2025Sep 30, 2025$82.99M+45.2%
Q2 FY2025Jun 30, 2025$74.23M+36.1%
Q1 FY2025Mar 31, 2025$70.89M+65.6%
Q4 FY2024Dec 31, 2024$140.18M+261.6%
Q3 FY2024Sep 30, 2024$57.15M+69.6%
Q2 FY2024Jun 30, 2024$54.53M+86.9%
Q1 FY2024Mar 31, 2024$42.81M+53.6%
Q4 FY2023Dec 31, 2023$38.77M+56.9%
Q3 FY2023Sep 30, 2023$33.70M+50.6%
Q2 FY2023Jun 30, 2023$29.18M+28.0%
Q1 FY2023Mar 31, 2023$27.86M+41.7%
Q4 FY2022Dec 31, 2022$24.71M+53.4%
Q3 FY2022Sep 30, 2022$22.37M+44.3%
Q2 FY2022Jun 30, 2022$22.80M+52.2%
Q1 FY2022Mar 31, 2022$19.66M+69.9%
Q4 FY2021Dec 31, 2021$16.11M+33.7%
Q3 FY2021Sep 30, 2021$15.50M+54.6%
Q2 FY2021Jun 30, 2021$14.98M+74.3%
Q1 FY2021Mar 31, 2021$11.57M+28.1%
Q4 FY2020Dec 31, 2020$12.05M+41.1%
Q3 FY2020Sep 30, 2020$10.03M+12.4%
Q2 FY2020Jun 30, 2020$8.60M-3.0%
Q1 FY2020Mar 31, 2020$9.03M+12.9%
Q4 FY2019Dec 31, 2019$8.54M+12.7%
Q3 FY2019Sep 30, 2019$8.92M-28.8%
Q2 FY2019Jun 30, 2019$8.86M+37.7%
Q1 FY2019Mar 31, 2019$8.00M–
Q4 FY2018Dec 31, 2018$7.58M–
Q3 FY2018Sep 30, 2018$12.54M–
Q2 FY2018Jun 30, 2018$6.43M–

More IDEAYA Biosciences figures

See a number that looks wrong?